Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Culture01:17

Stem Cell Culture

5.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

72.0K
Overview
72.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Hemoglobin-albumin-lymphocyte-platelet score associated with diabetic foot severity, unlike modified systemic immune-inflammatory index and modified systemic inflammatory response index.

Frontiers in endocrinology·2026
Same author

Solar radiation prediction using multivariate signal decomposition and physics-informed time-frequency feature extraction.

Communications engineering·2026
Same author

In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.

Blood advances·2026
Same author

Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.

Nature·2026
Same author

Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homing.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Video Experimental Relacionado

Updated: Sep 8, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K

La terapia con células madre frente al sistema inmunológico

Roberto Castro-Gutierrez1, Qizhi Tang2

  • 1Diabetes Center, University of California San Francisco, San Francisco, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, USA.

Cell stem cell
|September 5, 2025
PubMed
Resumen

Las terapias con células madre enfrentan desafíos de rechazo inmune debido a la falta de coincidencia de HLA. El análisis de ensayos clínicos revela estrategias para mitigar estos riesgos para mejores resultados de la terapia celular.

Más Videos Relacionados

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

533

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

533

Área de la Ciencia:

  • Inmunología
  • La Medicina Regenerativa
  • Ensayos clínicos

Sus antecedentes:

  • Las terapias con células madre están avanzando rápidamente, mostrándose prometedoras en varias aplicaciones clínicas.
  • Un obstáculo importante en la terapia con células madre es el riesgo de rechazo inmune por parte del huésped.
  • El desajuste del antígeno leucocitario humano (HLA) es el principal impulsor de esta respuesta inmune.

Objetivo del estudio:

  • Investigar los desafíos del rechazo inmune en los ensayos clínicos actuales de terapia con células madre.
  • Analizar el impacto del desajuste de HLA y la inmunosupresión en la eficacia de la terapia celular.
  • Identificar estrategias potenciales para mitigar los riesgos inmunológicos en los tratamientos con células madre.

Principales métodos:

  • Revisión de informes clínicos recientes y análisis inmunológicos de ensayos de terapia celular en curso.
  • Evaluación de las respuestas inmunológicas del paciente en relación con la compatibilidad HLA.
  • Evaluación de los protocolos de inmunosupresión y sus efectos.

Principales resultados:

  • Los datos clínicos ponen de relieve los desafíos significativos asociados con el desajuste de HLA en los receptores de células madre.
  • Las estrategias de inmunosupresión muestran un éxito variable en la prevención del rechazo.
  • Los marcadores inmunológicos específicos se correlacionan con los resultados del tratamiento.

Conclusiones:

  • Comprender el desajuste de HLA es crítico para el éxito del trasplante de células madre.
  • La inmunosupresión optimizada y el emparejamiento de donantes pueden mejorar la seguridad y eficacia de la terapia celular.
  • Se necesitan más investigaciones sobre los mecanismos de tolerancia inmune para avanzar en las terapias con células madre.